Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets

C Gao, J Jiang, Y Tan, S Chen - Signal transduction and targeted …, 2023 - nature.com
Microglia activation is observed in various neurodegenerative diseases. Recent advances in
single-cell technologies have revealed that these reactive microglia were with high spatial …

Targeting synapse function and loss for treatment of neurodegenerative diseases

B Dejanovic, M Sheng, JE Hanson - Nature Reviews Drug Discovery, 2024 - nature.com
Synapse dysfunction and loss are hallmarks of neurodegenerative diseases that correlate
with cognitive decline. However, the mechanisms and therapeutic strategies to prevent or …

Activation of retinal glial cells contributes to the degeneration of ganglion cells in experimental glaucoma

Y Miao, GL Zhao, S Cheng, Z Wang, XL Yang - Progress in retinal and eye …, 2023 - Elsevier
Elevation of intraocular pressure (IOP) is a major risk factor for neurodegeneration in
glaucoma. Glial cells, which play an important role in normal functioning of retinal neurons …

Molecular mechanisms underlying neuroinflammation elicited by occupational injuries and toxicants

D Pathak, K Sriram - International Journal of Molecular Sciences, 2023 - mdpi.com
Occupational injuries and toxicant exposures lead to the development of neuroinflammation
by activating distinct mechanistic signaling cascades that ultimately culminate in the …

Oxytocin alleviates cognitive and memory impairments by decreasing hippocampal microglial activation and synaptic defects via OXTR/ERK/STAT3 pathway in a …

J Jiang, Y Zou, C **e, M Yang, Q Tong, M Yuan… - Brain, Behavior, and …, 2023 - Elsevier
Background Sepsis-associated encephalopathy (SAE) is a diffuse brain dysfunction,
characterized by cognitive and memory impairments closely linked to hippocampal …

Complement-mediated synapse loss in Alzheimer's disease: mechanisms and involvement of risk factors

L Wen, D Bi, Y Shen - Trends in Neurosciences, 2024 - cell.com
The complement system is increasingly recognized as a key player in the synapse loss and
cognitive impairments observed in Alzheimer's disease (AD). In particular, the process of …

Biological mechanisms of resilience to tau pathology in Alzheimer's disease

AL Svenningsson, DI Bocancea, E Stomrud… - Alzheimer's Research & …, 2024 - Springer
Abstract Background In Alzheimer's disease (AD), the associations between tau pathology
and brain atrophy and cognitive decline are well established, but imperfect. We investigate …

[HTML][HTML] Aging and cognitive resilience: Molecular mechanisms as new potential therapeutic targets

A Cordeiro, C Gomes, J Bicker, A Fortuna - Drug Discovery Today, 2024 - Elsevier
As the global population ages, the need to prolong lifespan and healthspan becomes
increasingly imperative. Understanding the molecular determinants underlying cognitive …

Nicotinic Acetylcholine Receptors in Glial Cells as Molecular Target for Parkinson's Disease

ÉN Soares, ACS Costa, GJ Ferrolho, RP Ureshino… - Cells, 2024 - mdpi.com
Parkinson's disease (PD) is a progressive neurodegenerative disease characterized by
resting tremor, bradykinesia, rigidity, and postural instability that also includes non-motor …

Role of trigger receptor 2 expressed on myeloid cells in neuroinflammation-neglected multidimensional regulation of microglia

X Zhang, X Chen, L Zhang, Y Sun, Y Liang, H Li… - Neurochemistry …, 2023 - Elsevier
Neuroinflammation is an inflammatory cascade involved in various neurological disorders,
including Alzheimer's disease, multiple sclerosis, and other relevant diseases. The …